Mylan and Biocon gain approval for Herceptin biosimilar in India while Roche and ImmunoGen gain approval for Herceptin-DM1 combination Kadcyla in Europe.
Reported by Motley Fool 2 days ago.
Reported by Motley Fool 2 days ago.